Food products and allergy development, prevention and treatment

Current Opinion in Biotechnology

Volumn 17, Issue 2, 2006, Pages 198-203

  Zuercher, Adrian W ^a   Fritsché, Rodolphe ^a   Corthésy, Blaise ^b   Mercenier, Annick ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIES; DISEASE CONTROL; EPIDEMIOLOGY; GENETIC ENGINEERING; IMMUNIZATION; NUTRITION;

ALLERGY DEVELOPMENT; EPIDEMIC PROPORTIONS; FOOD ALLERGIES; FOOD INGREDIENTS;

FOOD PRODUCTS;

PROBIOTIC AGENT;

ALLERGENICITY; ALLERGY; ANAPHYLAXIS; ARTIFICIAL MILK; ATOPIC DERMATITIS; BACTERIAL STRAIN; BREAST FEEDING; CLINICAL FEATURE; FOOD ALLERGY; GENE SILENCING; GENETIC TRANSDUCTION; IMMUNE STATUS; IMMUNOMODULATION; LACTOBACILLUS RHAMNOSUS; MAST CELL DEGRANULATION; NONHUMAN; PEANUT ALLERGY; PRICK TEST; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; ANIMAL; DIET THERAPY; GENETICALLY MODIFIED FOOD; HUMAN; IMMUNOLOGY;

ANIMALIA;

ANIMALS; FOOD HYPERSENSITIVITY; FOOD, GENETICALLY MODIFIED; HUMANS; PROBIOTICS;

EID: 33744975020     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2006.01.010     Document Type: Review

References (39)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998, 351:1225-1232.
2. von Mutius E. Influences in allergy: epidemiology and the environment. J Allergy Clin Immunol 113 (2004) 373-379
3. Isolauri E., Rautava S., Kalliomaki M., Kirjavainen P., and Salminen S. Role of probiotics in food hypersensitivity. Curr Opin Allergy Clin Immunol 2 (2002) 263-271
4. Osterballe M., Hansen T.K., Mortz C.G., Host A., and Bindslev-Jensen C. The prevalence of food hypersensitivity in an unselected population of children and adults. Pediatr Allergy Immunol 16 (2005) 567-573
5. Sampson H.A. Update on food allergy. J Allergy Clin Immunol 113 (2004) 805-819
6. Moneret-Vautrin D.A., Morisset M., Flabbee J., Beaudouin E., and Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 60 (2005) 443-451
7. Strobel S., and Ferguson A. Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr Res 18 (1984) 588-594
8. Hays T., and Wood R.A. A systematic review of the role of hydrolyzed infant formulas in allergy prevention. Arch Pediatr Adolesc Med 159 (2005) 810-816. A comprehensive review on the use of partially and extensively hydrolyzed milk formula for allergy prevention.
9. Fritsche R., Pahud J.J., Pecquet S., and Pfeifer A. Induction of systemic immunologic tolerance to β-lactoglobulin by oral administration of a whey protein hydrolysate. J Allergy Clin Immunol 100 (1997) 266-273
10. Bhalla P.L., Swoboda I., and Singh M.B. Antisense-mediated silencing of a gene encoding a major ryegrass pollen allergen. Proc Natl Acad Sci USA 96 (1999) 11676-11680
11. Herman E.M., Helm R.M., Jung R., and Kinney A.J. Genetic modification removes an immunodominant allergen from soybean. Plant Physiol 132 (2003) 36-43
12. Gilissen L.J., Bolhaar S.T., Matos C.I., Rouwendal G.J., Boone M.J., Krens F.A., Zuidmeer L., Van Leeuwen A., Akkerdaas J., Hoffmann-Sommergruber K., et al. Silencing the major apple allergen Mal d 1 by using the RNA interference approach. J Allergy Clin Immunol 115 (2005) 364-369. A recent example showing that silencing of the major apple allergen results in reduced skin-prick reactivity and IgE binding.
13. Dodo H., Konan K., and Viquez O. A genetic engineering strategy to eliminate peanut allergy. Curr Allergy Asthma Rep 5 (2005) 67-73
14. Ferreira F., Ebner C., Kramer B., Casari G., Briza P., Kungl A.J., Grimm R., Jahn-Schmid B., Breiteneder H., Kraft D., et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 12 (1998) 231-242
15. Bergonzelli G.E., Blum S., Brussow H., and Corthesy-Theulaz I. Probiotics as a treatment strategy for gastrointestinal diseases?. Digestion 72 (2005) 57-68
16. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., and Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079. Prophylactic intervention with a probiotic resulted in a lower prevalence of atopic dermatitis in at-risk infants.
17. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
18. Lodinova-Zadnikova R., Cukrowska B., and Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 131 (2003) 209-211
19. Viljanen M., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., and Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60 (2005) 494-500
20. Viljanen M., Kuitunen M., Haahtela T., Juntunen-Backman K., Korpela R., and Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 16 (2005) 65-71
21. Weston S., Halbert A., Richmond P., and Prescott S.L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90 (2005) 892-897. Clinical study in at-risk infants showing significant reduction of the atopic dermatitis score after consumption of probiotics.
22. Frick O.L., Teuber S.S., Buchanan B.B., Morigasaki S., and Umetsu D.T. Allergen immunotherapy with heat-killed Listeria monocytogenes alleviates peanut and food-induced anaphylaxis in dogs. Allergy 60 (2005) 243-250
23. Zuany-Amorim C., Manlius C., Trifilieff A., Brunet L.R., Rook G., Bowen G., Pay G., and Walker C. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol 169 (2002) 1492-1499
24. Sayers I., Severn W., Scanga C.B., Hudson J., Le Gros G., and Harper J.L. Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol 114 (2004) 302-309
25. Bashir M.E., Louie S., Shi H.N., and Nagler-Anderson C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 172 (2004) 6978-6987
26. Braun-Fahrlander C., Riedler J., Herz U., Eder W., Waser M., Grize L., Maisch S., Carr D., Gerlach F., Bufe A., et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347 (2002) 869-877
27. Farkas L., Kvale E.O., Johansen F.E., Jahnsen F.L., and Lund-Johansen F. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J Allergy Clin Immunol 114 (2004) 436-443
28. Horner A.A., and Raz E. Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J Allergy Clin Immunol 110 (2002) 706-712
29. Adams V.C., Hunt J.R., Martinelli R., Palmer R., Rook G.A., and Brunet L.R. Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice. Eur J Immunol 34 (2004) 631-638
30. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., Bavari S., and Klaenhammer T.R. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 102 (2005) 2880-2885
31. Prioult G., and Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation?. Immunol Rev 206 (2005) 204-218
32. Frossard C.P., Hauser C., and Eigenmann P.A. Oral carrageenan induces antigen-dependent oral tolerance: prevention of anaphylaxis and induction of lymphocyte anergy in a murine model of food allergy. Pediatr Res 49 (2001) 417-422
33. Srivastava K.D., Kattan J.D., Zou Z.M., Li J.H., Zhang L., Wallenstein S., Goldfarb J., Sampson H.A., and Li X.M. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 115 (2005) 171-178
34. Albers R., Bol M., Bleumink R., Willems A., Blonk C., and Pieters R. Effects of dietary lipids on immune function in a murine sensitisation model. Br J Nutr 88 (2002) 291-299
35. Dunstan J.A., Mori T.A., Barden A., Beilin L.J., Taylor A.L., Holt P.G., and Prescott S.L. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 112 (2003) 1178-1184
36. Hsieh K.Y., Hsu C.I., Lin J.Y., Tsai C.C., and Lin R.H. Oral administration of an edible-mushroom-derived protein inhibits the development of food-allergic reactions in mice. Clin Exp Allergy 33 (2003) 1595-1602
37. Hoppu U., Rinne M., Salo-Vaananen P., Lampi A.M., Piironen V., and Isolauri E. Vitamin C in breast milk may reduce the risk of atopy in the infant. Eur J Clin Nutr 59 (2005) 123-128
38. Martindale S., McNeill G., Devereux G., Campbell D., Russell G., and Seaton A. Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life. Am J Respir Crit Care Med 171 (2005) 121-128
39. Fanaro S., Boehm G., Garssen J., Knol J., Mosca F., Stahl B., and Vigi V. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatr Suppl 94 (2005) 22-26